3.20

2.14% -0.07

After Hours: 3.21 0.010 +0.31%

Alaunos Therapeutics Inc (TCRT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Alaunos Therapeutics Inc stock is traded at $3.20, with a volume of 12,204. It is down -2.14% in the last 24 hours and down -11.36% over the past month. Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Previous Close:

$3.27

Open:

$3.24

24h Volume:

12,204

Relative Volume:

0.03

Market Cap:

$7.14M

Revenue:

$6,000

Net Income/Loss:

$-3.99M

P/E Ratio:

-1.2985

EPS:

-2.4643

Net Cash Flow:

$-2.85M

1W Performance:

-5.04%

1M Performance:

-11.36%

6M Performance:

-36.00%

1Y Performance:

+67.54%

1-Day Range:

$3.20

$3.3099

1-Week Range:

$3.13

$3.34

52-Week Range:

$1.3137

$6.20

Alaunos Therapeutics Inc Stock (TCRT) Company Profile

Name

Alaunos Therapeutics Inc

Sector

Healthcare (1114)

Industry

Biotechnology (625)

Phone

(346) 355-4099

Address

501 E LAS OLAS BLVD, FORT LAUDERDALE

Employee

Twitter

Next Earnings Date

2024-12-12

Latest SEC Filings

TCRT's Discussions on Twitter

Compare TCRT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TCRT Alaunos Therapeutics Inc	3.20	7.30M	6,000	-3.99M	-2.85M	-2.4643
VRTX Vertex Pharmaceuticals Inc	468.38	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.54	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	406.40	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.74	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.07	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-04-22	Resumed	Wells Fargo	Overweight

Alaunos Therapeutics Inc Stock (TCRT) Latest News

Jan 05, 2026

Retail Surge: Will Alaunos Therapeutics Inc stock maintain dividend yield2025 Dividend Review & AI Forecasted Entry and Exit Points - moha.gov.vn

Jan 05, 2026

Dec 30, 2025

Will Alaunos Therapeutics Inc stock attract more institutional investorsM&A Rumor & Accurate Entry/Exit Alerts - moha.gov.vn

Dec 30, 2025

Dec 23, 2025

Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices - Investing.com Canada

Dec 23, 2025

Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer - TipRanks

Dec 23, 2025

Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices By Investing.com - Investing.com South Africa

Dec 23, 2025

Dec 20, 2025

Why Alaunos Therapeutics Inc. stock could rally in 2025Wall Street Watch & Free Risk Controlled Daily Trade Plans - Улправда

Dec 20, 2025

Dec 19, 2025

Why Alaunos Therapeutics Inc. stock is seen as undervaluedJuly 2025 Closing Moves & Low Risk High Reward Trade Ideas - Улправда

Dec 19, 2025

Risk Check: Can Alaunos Therapeutics Inc. stock outperform in 2025 bull market - Улправда

Dec 19, 2025

Will Alaunos Therapeutics Inc. stock maintain dividend yieldEarnings Growth Summary & Consistent Return Investment Signals - DonanımHaber

Dec 19, 2025

Will Alaunos Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Momentum & High Return Stock Watch Alerts - DonanımHaber

Dec 19, 2025

Will Alaunos Therapeutics Inc. stock split again soon2025 Trading Recap & Capital Protection Trade Alerts - DonanımHaber

Dec 19, 2025

Is Alaunos Therapeutics Inc. stock attractive after correctionWeekly Risk Report & Consistent Profit Trade Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

How strong is Alaunos Therapeutics Inc. stock revenue growthSell Signal & Real-Time Chart Pattern Alerts - ulpravda.ru

Dec 18, 2025

Stop Loss: Why Alaunos Therapeutics Inc. stock is seen as undervaluedGlobal Markets & Weekly High Return Stock Forecasts - Улправда

Dec 18, 2025

Dec 11, 2025